Viral, host and therapeutic factors affecting T-cell recovery in virologically controlled HIV patients

Author： Pinnetti Carmela   Bandera Alessandra   Mangioni Davide   Gori Andrea  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.9, 2012-09, pp. : 911-921

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef

By Saxena Shailendra K   Shrivastava Gaurav   Tiwari Sneham   Swamy ML Arvinda   Nair Madhavan PN  

Future Virology, Vol. 7, Iss. 6, 2012-06 ,pp. : 609-620

Future Medicine

Access to resources Recommend Favorite

Infliximab linked to T-cell lymphoma in young patients

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

XII. Therapeutic exploitation of autologous T‐cell activation in B‐cell lymphoma

By  

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 67-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

HIV-1 transmission and viral adaptation to the host

By Gijsbers Esther F   Schuitemaker Hanneke   Kootstra Neeltje A  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 63-71

Future Medicine

Access to resources Recommend Favorite

Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications

By Testa James S   Philip Ramila  

Future Virology, Vol. 7, Iss. 11, 2012-11 ,pp. : 1077-1088

Future Medicine

Access to resources Recommend Favorite